Development of a Registry for the Study of Opioid Utilization in Chronic Noncancer Pain Management
Charles Argoff, MD1; Leanne Yanni, MD2; Steven Stanos, DO3; Gordon Irving, MD4; and the OPUS Group
1Department of Neurology, Albany Medical College, Albany, NY; 2Division of General Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA; 3Rehabilitation Institute of Chicago Center for Pain Management, Northwestern University Medical School, Chicago, IL; 4Swedish Pain and Headache Center, University of Washington, Seattle, WA
View Abstract
Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients with vs Without Major Depressive Disorder
Lesley M. Arnold1, James I. Hudson2, Fujun Wang3, Madelaine M. Wohlreich3, Apurva Prakash3, Daniel K. Kajdasz3, Elijah Frakes3, Amy S. Chappell3
1Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH; 2McLean Hospital, Belmont, MA, and Department of Psychiatry, Harvard Medical School, Boston, MA; 3Eli Lilly and Company, Indianapolis, IN
View Abstract
Efficacy of Duloxetine in Patients with Fibromyalgia: Pooled Analysis of Four Placebo-controlled Clinical Trials
Lesley M. Arnold1, Daniel Clauw2, Madelaine Wohlreich3, Fujun Wang3, Jonna Ahl3, Paula J Gaynor3, Elijah Frakes3, Amy S. Chappell3
1Women's Health Research Program, University of Cincinnati College of Medicine, Cincinnati, OH; 2Division of Rheumatology, Chronic Pain and Fatigue Research Center, University of Michigan Medical Center, Ann Arbor, MI; 3Eli Lilly and Company, Indianapolis, IN
View Abstract
Pain from Carpal Tunnel Syndrome Reduced with Dynamic Splinting
Stacey H. Berner, MD1; F. Buck Willis, PhD2; Ramalingam Shanmugam, PhD3
1Advanced Centers for Orthopaedic Surgery and Sports Medicine, Eldersberg, MD; 2Texas State University-San Marcos [at the time of this study] and Clinical Research, Dynasplint Systems, Inc, Austin, TX; 3School of Health Administration, Texas State University-San Marcos, San Marcos, TX
View Abstract
Improving Medication Error Reporting in Hospice Care
Rachel Boyer, PharmD; Mary Lynn McPherson, PharmD, BCPS, CDE; Guarav Deshpande, PharmD, MS; Shelia Weiss Smith, PhD
University of Maryland School of Pharmacy, Baltimore, MD
View Abstract
Time to Onset of Relief from Acute Pain Due to Minor Ankle Sprain After Treatment with Diclofenac Epolamine Topical Patch
Alan Brewer,1 Jillmarie Yanchick,2 A. Lanzarotti,3 Cynthia Fuller4
1University of Colorado Health Sciences Center, Denver, CO; 2Alpharma Pharmaceuticals LLC, Piscataway, NJ; 3Institut Biochimique SA, Pambio-Noranco, Switzerland; 4MMS Holdings Inc., Canton, MI
View Abstract
Diclofenac Epolamine Topical Patch (DETP) Offers a Safe Treatment Alternative to Oral NSAIDs in Treatment of Minor Soft Tissue Injuries
Alan Brewer1; Jillmarie Yanchick2; Stefano Rovati3; Cynthia Fuller4
1Department of Anesthesiology, University of Colorado, Denver, CO; 2Alpharma Pharmaceuticals LLC, Piscataway NJ; 3Institut Biochemique SA, Pambio-Noranco, Switzerland; 4MMS Holdings, Inc., Canton, MI
View Abstract
Duloxetine 60 to 120 mg vs Placebo in the Treatment of Patients with Osteoarthritis Knee Pain
Amy S. Chappell, MD1; Melissa J Ossanna, PhD1; Hong Liu-Seifert, PhD1; Jerry Hall, MD1; Harry Collins, MD2
1Lilly Research Laboratories, Indianapolis, IN; 2Anderson & Collins Clinical Research, Inc., Edison, NJ
View Abstract
Efficacy of Milnacipran in the Treatment of Fibromyalgia: A 15-week, Double-blind, Placebo-controlled Trial
Daniel J. Clauw, MD1; Philip J. Mease, MD2; Robert H. Palmer, MD3; Kim Thacke, MDr3; R. Michael Gendreau, MD, PhD4, Tobie Escher, PhD3
1University of Michigan, Division of Rheumatology, Ann Arbor, MI; 2Seattle Rheumatology Associates and Swedish Medical Center, Internal Medicine and Rheumatology, Seattle, WA; 3Forest Research Institute, Jersey City, NJ; 4Cypress Bioscience, Inc., San Diego, CA
View Abstract
Exploring the Educational Value of Endurance in the Context of Acute Pain
Nance Cunningham, Doctoral Candidate
Department of Educational Leadership and Policy Studies, University of Oklahoma, Norman, OK
View Abstract
The Safety and Efficacy of Oral Diclofenac Soft Gelatin, Liquid-filled Capsules for Postbunionectomy Pain
Stephen E. Daniels, DO1; Douglas R. Baum, MS1; Stephen E. Boesing, MS2
1SCIREX Research Centers, Austin, Texas; 2 Xanodyne Pharmaceuticals, Inc, Clinical Development and Scientific Affairs, Newport, KY
View Abstract
Effect of Food on the Pharmacokinetics of Once-daily Cyclobenzaprine Extended-release 30 mg
Mona Darwish, PhD
Cephalon, Inc., Frazer, PA
View Abstract
Comparison of the Pharmacokinetics of Once-daily Cyclobenzaprine Extended-release 30 mg and Cyclobenzaprine Immediate-release 10 mg Three Times Daily
Mona Darwish, PhD; Steven C.K. Chang, PhD; Edward Hellriegel, PhD
Cephalon, Inc., Frazer, PA
View Abstract
Comparison of Pharmacokinetics and Tolerability Following a Single Dose of Once-daily Cyclobenzaprine Extended-release 15 mg and 30 mg
Mona Darwish, PhD; Steven C.K. Chang, PhD; Edward T. Hellriegel, PhD
Cephalon, Inc., Frazer, PA
View Abstract
Fentanyl Buccal Tablet in Opioid-tolerant Patients with Noncancer-Related Breakthrough Pain: A 12-week Study Using a Novel Double-blind, Placebo-controlled Design
John T. Farrar,1 Edward Michna,2 John Messina,3 Fang Xie, PhD3
1Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA; 2Brigham & Women's Hospital, Boston, MA; 3Cephalon, Inc., Frazer, PA
View Abstract
Long-term Safety of Fentanyl Buccal Tablet in Opioid-tolerant Patients with Chronic Noncancer Pain and Breakthrough Pain
Perry G. Fine,1 James Rathmell,2 John Messina,3 Fang Xie3
1University of Utah, Salt Lake City, UT; 2Massachusetts General Hospital, Boston, MA; 3Cephalon, Inc., Frazer, PA
View Abstract
Opioid Prescribing Practices in Chronic Pain Management: Guidelines Do Not Ensure Good Clinical Practice
Errol Gould, PhD; Nancy Alvarez, PharmD; Timothy W. Victor, PhD
Endo Pharmaceuticals Inc, Chadds Ford, PA, USA
View Abstract
Oxymorphone Extended Release in Hydrocodone-experienced Patients with Chronic Low Back Pain: Subgroup Analysis of a 12-Week, Randomized, Double-blind, Placebo-controlled Study
Errol Gould, PhD,1 Martin Hale, MD,2 Tina Ma, PhD,1 Harry Ahdieh, PhD,1 Rosemary Kerwin, PharmD1
1Endo Pharmaceuticals Inc., Chadds Ford, PA, USA, 2Gold Coast Research, LLC, Weston,
FL, USA
View Abstract
Efficacy of Oxymorphone Extended Release in Opioid-experienced Patients with a Herniated Disc: Subgroup Analysis of a Randomized, Double-blind, Placebo-controlled Trial
Errol Gould, PhD,1 Martin Hale, MD,2 Tina Ma, PhD,1 Harry Ahdieh, PhD,1 Rosemary Kerwin, PharmD1
1Endo Pharmaceuticals Inc., Chadds Ford, PA; 2Gold Coast Research, LLC, Weston,
FL, USA
View Abstract
Long-term Treatment of Diabetic Neuropathy with Lacosamide
Ronald Graf1 for the SP745 Study Group; Wendy Frye2; Jeff Simpson2; Gary Jay2
1Cedar Research, Tacoma, WA, 2Schwarz Biosciences, Inc., Raleigh, NC
View Abstract
A Novel Three-Dimensional Pain Drawing
Jerry Hesch, MHS, PT
Hesch Method Seminars and Physical Therapy, LLC, Henderson, NV
View Abstract
Long-term Efficacy of Lacosamide in Subjects with Painful Distal Diabetic Neuropathy: Results of a Double-Blind, Randomized Withdrawal Trial
Dr. Tibor Hidvégi for the SP 746 Study Group1, Michael Bretschneider2, Stephan Thierfelder2, Ken Sommerville3, Sabine Bongardt 2
1Petz Aladár Hospital, GyÐr, Hungary, 2Schwarz BioSciences, Inc., Monheim, Germany, 3formerly affiliated with Schwarz BioSciences, Inc., Raleigh, NC
View Abstract
Assessing the Societal Burden of Prescription Opioid Abuse Among Patients with Chronic Pain: A Conceptual Model
Jing Ju, PharmD1; Mary Lynn McPherson, PharmD, BCPS, CDE2; Anthony Tommasello, PhD1; C. Daniel Mullins, PhD1
1Pharmaceutical Health Services Research, University of Maryland School of Pharmacy Baltimore, MD; 2Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD
View Abstract
Pilot: Effectiveness and Safety of Non-surgical Spinal Decompression
John Leslie1; Charlotte Richmond2; Alex Macario3; Christian Apfel4; Frank Florio5; Marty Auster6; Joseph Pergolizzi6
1Mayo Clinic, Scottsdale, AZ, USA; 2NEMA Research, Inc., Naples, FL; 3Stanford University, Stanford, CA; 4University of California at San Francisco, San Francisco, CA; 5Axiom Worldwide, Inc, Tampa, FL; 6Johns Hopkins University, Baltimore, MD
View Abstract
Radicular Pain Unmasked following Percutaneous Vertebroplasty
Mahesh P. Mehta, MD; Claude Brunson, MD
Department of Anesthesiology, University of Mississippi Medical Center, Jackson, MS
View Abstract
Pharmacokinetic Comparison of Oral Diclofenac Potassium Soft Gelatin Liquid Filled Capsule versus Diclofenac Potassium Tablet in Volunteers and Bunionectomy Patients
Keith A. Moore, PharmD1; Douglas G. Stoker, DPM2; Michael Lissy, MD3
1Xanodyne Pharmaceuticals, Newport, KY; 2Podiatry Center, Salt Lake City, UT; 3AAIPharma, Neu-Ulm, Germany
View Abstract
Single-Dose Pharmacokinetic Comparison of ProSorb® Diclofenac Potassium Formulations in Healthy Adult Volunteers
Keith A. Moore, PharmD1; Dwight D. Stiff, PhD2; Michael Lissy, MD2; Stephen E. Boesing, MS1
1Xanodyne Pharmaceuticals, Newport, KY; 2AAIPharma, Neu-Ulm, Germany
View Abstract
Impact of Long-Term Use of Fentanyl Buccal Tablet on Novel Measures of Functioning in Opioid-Tolerant Patients with Chronic Noncancer Pain and Breakthrough Pain
Srinivas Nalamachu,1 John Messina,2 Fang Xie2
1Mid-America Physiatrists, PA, Overland Park, KS; 2Cephalon, Inc., Frazer, PA
View Abstract
Oral Diclofenac Soft Gelatin Liquid Filled Capsule Is Efficacious Compared with Placebo in Patients with Postsurgical Dental Pain
Robert J. Noveck, MD, PhD1; John R. Zuniga, DMD, PhD2; John H. Campbell, DDS, MS3; Hans Malmström, DDS4; Boyd J. Tomasetti, DMD5; Stephen E. Boesing, MS6
1MDS Pharma Services (US), Inc, Neptune, NJ; 2University of Texas Southwestern Medical Center, Dallas, TX; 3University at Buffalo, School of Dental Medicine, Buffalo, NY; 4The University of Rochester, Rochester, NY; 5Rocky Mountain Oral and Maxillofacial Surgery, Littleton, CO; 6Clinical Development and Scientific Affairs, Xanodyne Pharmaceuticals, Inc, Newport, KY
View Abstract
Decreased Lower Back Pain after Non-Invasive Spinal Decompression May be Due to Restored Disc Height
Joseph V. Pergolizzi1; Christian Apfel2; Frank Florio3; William Martin4; Charlotte Richmond5
1Johns Hopkins University, Baltimore, MD; 2University of California at San Francisco, San Francisco, CA; 3Axiom Worldwide, LLC, Tampa, FL; 4Upper Valley Interventional Radiology, McAllen, TX; 5NEMA Research, Inc., Naples, FL
View Abstract
Duloxetine vs α2&sigma Ligands in Painful Diabetic Neuropathy
Sibilia Quilici1; Jeremy Chancellor1; Mickael Lothgren2; Dominque Simon3; Gerard Said4; T. Kim Le5; Ana Garcia-Cebrian6; Daniel Kajdasz5; Wahiba Estergard5
1 i3 Innovus, Middlesex, UK; 2 Janssen-Cilag AB, Sollentuna, Sweden; 3Service de Diabétologie Hôpital de la Pitié, Paris, France; 4Hôpital de Bicêtre, Paris, France; 5Eli Lilly and Company, Indianapolis, IN; 6Eli Lilly and Company, Windlesham,UK
View Abstract
Time to Onset of Pain Relief in Dental Surgery Patients Administered Oral Diclofenac Potassium Soft Gelatin Liquid Filled Capsule
William K. Schmidt, PhD1; Stephen E. Boesing, MS2; John H. Campbell, DDS, MS3; Hans Malmstrom, DDS4; Robert J. Noveck, MD, PhD5; Boyd J. Tomasetti, DMD6; John R. Zuniga, DMD, PhD7
1NorthStar Consulting, LLC, Davis, CA; 2Clinical Development and Scientific Affairs, Xanodyne Pharmaceuticals, Inc., USA; 3University at Buffalo, School of Dental Medicine, Buffalo, NY; 4The University of Rochester, Rochester, NY; 5MDS Pharma Services (US), Inc, Neptune, NJ; 6Rocky Mountain Oral and Maxillofacial Surgery, Littleton, CO; 7University of Texas Southwestern Medical Center, Dallas, TX
View Abstract
Efficacy and Safety of Duloxetine 60 mg to 120 mg Once Daily in Patients with Chronic Low Back Pain
Vladimir Skljarevski, MD1; Durisala Desaiah, PhD1; Hong Liu-Seifert, PhD1; Qi Zhang, PhD1; J Hampton Atkinson2; Jerry Hall, MD1; Miroslav Backonja, MD3
1Lilly Research Laboratories, Indianapolis, IN; 2VA San Diego Healthcare System, San Diego, CA; 3University of Wisconsin Medical School, Madison, WI
View Abstract
Chronic Pain Relief Through Patient and Provider Education
Michael S. Snyder, MD, PhD
View Abstract
Development of the LAQ: A New Questionnaire for Detecting Deception in the Chronic Pain Population. A Validation Study Comparing Two Dissimulation Groups
Blake H. Tearnan, PhD
HealthNetSolutions.com
View Abstract
